Viking Therapeutics (VKTX) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 27.68 +1.59 (6.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.09 | 52 Week High | $5.17 | |||
| Open | $26.91 | 52 Week Low | $0.94 | |||
| Day High | $27.76 | P/E | N/A | |||
| Day Low | $26.09 | EPS | $0.00 | |||
| Volume | 2,060,216 | |||||
